Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Share-based Compensation (2023 - 2025)

Fractyl Health's Share-based Compensation history spans 3 years, with the latest figure at $1.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 36.01% year-over-year to $1.9 million, compared with a TTM value of $6.7 million through Dec 2025, down 53.67%, and an annual FY2025 reading of $6.7 million, down 53.67% over the prior year.
  • Share-based Compensation for Q4 2025 was $1.9 million at Fractyl Health, up from $1.6 million in the prior quarter.
  • The five-year high for Share-based Compensation was $5.2 million in Q1 2024, with the low at $857000.0 in Q1 2023.
  • Average Share-based Compensation over 3 years is $2.1 million, with a median of $1.7 million recorded in 2025.
  • Year-over-year, Share-based Compensation skyrocketed 508.75% in 2024 and then tumbled 73.05% in 2025.
  • Tracing GUTS's Share-based Compensation over 3 years: stood at $1.3 million in 2023, then soared by 127.19% to $2.9 million in 2024, then tumbled by 36.01% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Share-based Compensation are $1.9 million (Q4 2025), $1.6 million (Q3 2025), and $1.8 million (Q2 2025).